Related Experiment Video
Updated: May 4, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
p-Stat3 and bcr/abl gene expression in chronic myeloid leukemia and their relation to imatinib therapy
Douaa Sayed1, Hosny Badrawy1, Noha Gaber1
1Department of Clinical Pathology, South Egypt Cancer Institute, Assiut University, Egypt.
Abstract:
Flowcytometry analysis was carried out to evaluate the expression of the p-Stat3 in 50 CML patients and 20 age-matched healthy controls. p-Stat3 expression was increased in advanced stages of CML. Imatinib treatment was found to suppress the expression of p-Stat3 in bone marrow cells. The level of p-Stat3 was found to be higher in resistant cases than in responsive cases, which suggest the beneficial use of p-Stat3 as an indicator to follow the clinical course and the treatment response.
Related Concept Videos
Abnormal Proliferation
The JAK-STAT Signaling Pathway

